Abiopharma

Clinical trial NCT07142655 updates: 1. completion date: 2025-10-31 → 2026-03-09 2. primary completion date: 2025-10-31 → 2026-03-09

Clinical trial NCT06577298 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07222852 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-11-15 → 2026-01-01

Clinical trial NCT04826237 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2025-12-31 → 2025-10-30 3. primary completion date: 2025-10-01 → 2025-10-30 4. enrollment: 100 → 3 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06944639 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-06-25 3. primary completion date: 2026-07-31 → 2026-06-25

Clinical trial NCT06659549: collaborators removed: Lexitas Pharma Services, Inc..

Clinical trial NCT06112743 updates: 1. completion date: 2026-07-09 → 2027-07-10 2. primary completion date: 2026-07-09 → 2026-07-16

Clinical trial NCT05093634 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-31 → 2026-06-30

Clinical trial NCT07071532 updates: 1. status: ACTIVE_NOT_RECRUITING → NOT_YET_RECRUITING 2. start date: 2025-07-15 → 2026-08-21 3. completion date: 2025-11-01 → 2027-02-01 4. primary completion date: 2025-11-01 → 2027-02-01

Clinical trial NCT07573436: start date: 2026-06-01 → 2026-08-01.

Clinical trial NCT04967365 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. primary completion date: 2026-06-30 → 2026-01-31

Clinical trial NCT06483100 updates: 1. completion date: 2031-12-31 → 2032-06-30 2. primary completion date: 2031-12-31 → 2032-06-30

Clinical trial NCT06870617: primary completion date: 2026-07-01 → 2026-10-01.

Clinical trial NCT05850676 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-12-30 → 2026-08-03 3. primary completion date: 2026-09-30 → 2026-08-03 4. enrollment: 45 → 54 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT02561234 updates: 1. start date: 2015-10-01 → 2015-10-22 2. completion date: 2019-05-01 → 2019-05-28 3. primary completion date: 2019-05-01 → 2019-05-28 4. enrollment: 98 → 76 participants 5. allocation: RANDOMIZED → NON_RANDOMIZED 6. collaborators added: Aeglea Biotherapeutics (Study sponsor)